Azacitidine (5-Azacytidine)

For research use only.

Catalog No.S1782 Synonyms: 5-AzaC,Ladakamycin, AZA,5-Aza, CC-486

56 publications

Azacitidine (5-Azacytidine) Chemical Structure

CAS No. 320-67-2

Azacitidine (5-Azacytidine, 5-AzaC, Ladakamycin, AZA, 5-Aza, CC-486) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases. Azacitidine induces mitochondrial apoptosis and autophagy.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 130 In stock
USD 97 In stock
USD 270 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Azacitidine (5-Azacytidine) has been cited by 56 publications

Purity & Quality Control

Choose Selective DNA Methyltransferase Inhibitors

Biological Activity

Description Azacitidine (5-Azacytidine, 5-AzaC, Ladakamycin, AZA, 5-Aza, CC-486) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases. Azacitidine induces mitochondrial apoptosis and autophagy.
Targets
DNA methyltransferase [1]
(Cell-free assay)
In vitro

Azacitidine is widely used to demonstrate the correlation between loss of methylation in specifc gene regions and activation of the associated genes. After incorporation into DNA, Azacitidine inhibits DNA methyltransferase noncompetitively, causing a block in cytosine methylation in newly replicated DNA but not in resting, nondividing cells. [1] Azacitidine induces differentiation of Friend Erythroleukemia Cell C3H10T1/2 with myotube formation. [2] Azacitidine can be activated to the nucleoside triphosphate and incorporate into both DNA and RNA, leading to inhibition of DNA, RNA and protein synthesis in normal eukaryotic cells and in cancer cell lines, which could finally leads to cell death. Azacitidine also inhibits the incorporation of purine metabolites into macromolecules. Azacitidine inhibits the L1210 cells growth with IC50 and of 0.019 μg/mL. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Raji  NYf5T|dET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlW4NE4yNTVyIN88US=> M1fYXFEzNTd{IHi= NGe4XHZqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2ViZHXw[Y5l\W62IH3hco5meg>? NFXxW4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzN|I1Pid-Mk[xN|MzPDZ:L3G+
Jurkat  MnfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYKwMlEuPTBizszN MXmxNk04OiCq Ml3jbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmKGSncHXu[IVvfCCvYX7u[ZI> M{nY[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUOzNlQ3Lz5{NkGzN|I1PjxxYU6=
CA46 NEn6UXdHfW6ldHnvckBCe3OjeR?= NVPOcJVROjEEoNM1US=> NH\j[201QCCq MWXpcoNz\WG|ZYRCpHBVWExzwrDtVm5CKGW6cILld5Nqd25? MnvxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{OyOFYoRjJ4MUOzNlQ3RC:jPh?=
Raji  NVT5OJJOTnWwY4Tpc44hSXO|YYm= NFPuR4IyPcLiwsXN MXe0PEBp M2HmeYlv[3KnYYPld:KhWFSSTEJCpI1TVkFiZYjwdoV{e2mxbh?= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|M{K0Okc,OjZzM{OyOFY9N2F-
Jurkat  NYPUfVZpTnWwY4Tpc44hSXO|YYm= M1rOT|MvPcLiwsXN M2ToclQ5KGh? MX\pcoNz\WG|ZYRCpHBVWExzwrDtVm5CKGW6cILld5Nqd25? M1W1fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUOzNlQ3Lz5{NkGzN|I1PjxxYU6=
MDA-MB-231 NHrw[ZBHfW6ldHnvckBCe3OjeR?= MXSxM|IvPS93IN88US=> NWO1UYltPDhiaB?= NIH6VZdl\WO{ZXHz[ZMhfGinIGDUVG4yOiCneIDy[ZN{cW:wIHH0JJRp\SClb37j[ZJvfHKjdHnvckBw\iB3wrFOwG0hPDkEoHi= NWn3b2Y1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVczOjlpPkK1PFE4OjJ7PD;hQi=>
MDA-MB-231 Mkf6SpVv[3Srb36gRZN{[Xl? MnHJNU8zNjVxNTFOwG0> M1Gw[FQ5KGh? NUTPR|BUcW6lcnXhd4V{KHSqZTDs[ZZmdHNib3[gSU1k[WSqZYLpckBuWk6DIHH0JJRp\SClb37j[ZJvfHKjdHnvckBw\iB{LkZCpO69VW[xcjC0POKhcA>? M1LJW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEG3NlI6Lz5{NUixO|IzQTxxYU6=
MDA-MB-231 MVPGeY5kfGmxbjDBd5NigQ>? MV:xM|IvPS93IN88US=> MYqyOE81QCCq M3vGfolv\HWlZYOgJJNq\26rZnnjZY51KFCDUmCgZ4xm[X[jZ3WgZYZ1\XJiNEigbC=> NVTkbHJRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVczOjlpPkK1PFE4OjJ7PD;hQi=>
MCF-7 NXqxWJNDTnWwY4Tpc44hSXO|YYm= MWixM|IvPS93IN88US=> M4rBOFI1NzR6IHi= MWLpcoNz\WG|ZYOgVGFTWCClbHXheoFo\cLi NUDzXXZ3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4NVczOjlpPkK1PFE4OjJ7PD;hQi=>
MDA-MB-231  MX\GeY5kfGmxbjDBd5NigQ>? MkTiNU8zNjVxNTFOwG0> NXnodZQ4OjRxNEigbC=> NG\NNZhqdmO{ZXHz[ZMhfGinIHX4dJJme3Orb36gc4YhdWmUTlGtNVI1KGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2KM7:TR?= NF6yU4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixO|IzQSd-MkW4NVczOjl:L3G+
A498 M2nNW2Z2dmO2aX;uJGF{e2G7 NGHwOosyOCEEtV2= NW\PVGpxPzJiaB?= MX\pcoR2[2W|IITo[UBCTEGPVGOxPEBo\W6nIHX4dJJme3Orb36= NIXsTI89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUW2PVA5Pid-MkW1OlkxQDZ:L3G+
CaKI-2 Ml75SpVv[3Srb36gRZN{[Xl? MVexNEDDvU1? NHe1THU4OiCq NF3GbIJqdmS3Y3XzJJRp\SCDRFHNWHMyQCCpZX7lJIV5eHKnc4Ppc44> NUWzd5A5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1OlkxQDZpPkK1OVY6ODh4PD;hQi=>
Ketr-3 NH7ZSIVHfW6ldHnvckBCe3OjeR?= Mm\JNVAhyrWP M3XPeFczKGh? Mme2bY5lfWOnczD0bIUhSUSDTWTTNVgh\2WwZTDlfJBz\XO|aX;u Mn3mQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3NkmwPFYoRjJ3NU[5NFg3RC:jPh?=
A253 M1;nV2Z2dmO2aX;uJGF{e2G7 NV;SOmNKOTBiwsXN Mmq5NE01KGR? NYPGblBHcW6lcnXhd4V{KHSqZTDtVm5CKGW6cILld5Nqd25ibHX2[Ywhd2ZidHjlJG0{WsLiYX\0[ZIhOjRiaB?= NFfCNmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS4OVU{Pid-MkW0PFU2OzZ:L3G+
A253 MWDGeY5kfGmxbjDBd5NigQ>? MVixNEDDvU1? MWq3NkBp M{XRTolv[3KnYYPld{B1cGViZYjwdoV{e2mxbjDs[ZZmdCCxZjD0bIUhVTOUIHnuJIJwfGhibXXtZpJidmViYX7kJIN6fG:|b3zpZ{BxemWyYYLheIlwdnN? M1\FeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NEi1OVM3Lz5{NUS4OVU{PjxxYU6=
A253 NYHRSodlTnWwY4Tpc44hSXO|YYm= NH\w[20yOCEEtV2= Mnr4NE01KGR? NWTuXWR2emWmdXPld{B1cGViNT3t[ZRpgWyleYTvd4lv\SClb370[Y51 MkLOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2OEW1N|YoRjJ3NEi1OVM3RC:jPh?=
PC3 Mny4SpVv[3Srb36gRZN{[Xl? NX3UVnVrOC5{IN88UeKh MlfoOEBl NVW2OpZKcW6lcnXhd4V{KHSqZTDn[Y5mKGW6cILld5Nqd25ib3[gTWdHSlB5LDDTSnJROSCjbnSgV2xEPkFzNTDjc41jcW6nZDD3bZRpKEeVS{GyOi=> NYPMemJoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|c{PDBpPkK1OFc4OzRyPD;hQi=>
MCF7 MXjGeY5kfGmxbjDBd5NigQ>? M3vUc|AvOyEQvF5CpC=> NGW0UnU1KGR? M4H4d4lv[3KnYYPld{B1cGViZ3Xu[UBmgHC{ZYPzbY9vKG:oIFnHSmJRPyxiU1\SVFEh[W6mIGPMR|ZCOTViY3;tZolv\WRid3n0bEBIW0tzMk[= NULpPG5GRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|c{PDBpPkK1OFc4OzRyPD;hQi=>
PC3 M1PZemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGry[nYxNjJizszNxsA> NX3FcY1JPCCm MmDO[IVkemWjc3XzJJRp\SClZXzsJIdzd3e2aDD0c{AzOC5|JTDjc41jcW6nZDD3bZRpKEeVS{GyOi=> NYG3Z5FWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|c{PDBpPkK1OFc4OzRyPD;hQi=>
MCF7 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\ESXcxNjNizszNxsA> MWS0JIQ> MU\k[YNz\WG|ZYOgeIhmKGOnbHyg[5Jwf3SqIEK0MlgmKGOxbXLpcoVlKHerdHigS3NMOTJ4 NFrmcGg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS3O|M1OCd-MkW0O|c{PDB:L3G+
BGC-823 NHv5c2NHfW6ldHnvckBCe3OjeR?= MnrLOeKh|ryP MXO3NkBp NUWxZmVi\GWlcnXhd4V{KHSqZTDQVmwuOyCycn;0[YlvKGyndnXsJJNq\26rZnPhcpRtgQ>? MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR5NUezN{c,OjV2N{W3N|M9N2F-
MKN28 MkS3SpVv[3Srb36gRZN{[Xl? MYS1xsDPxE1? NV6yW4dKPzJiaB?= MmTK[IVkemWjc3XzJJRp\SCSUlytN{Bxem:2ZXnuJIxmfmWuIIPp[45q\mOjboTsfS=> Mm\ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2N{W3N|MoRjJ3NEe1O|M{RC:jPh?=
SGC-7901 NELL[41HfW6ldHnvckBCe3OjeR?= NEnaeHE2yqEQvF2= MmK4O|IhcA>? M4H1eIRm[3KnYYPld{B1cGViUGLMMVMheHKxdHXpckBt\X[nbDDzbYdvcW[lYX70cJk> Mn\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2N{W3N|MoRjJ3NEe1O|M{RC:jPh?=
MKN45 MXnGeY5kfGmxbjDBd5NigQ>? NGPCVYM2yqEQvF2= M2\XfFczKGh? Mljw[IVkemWjc3XzJJRp\SCSUlytN{Bxem:2ZXnuJIxmfmWuIIPp[45q\mOjboTsfS=> NVG3VZZiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|U4OzNpPkK1OFc2PzN|PD;hQi=>
BGC-823 NFLNW4ZHfW6ldHnvckBCe3OjeR?= MlezOeKh|ryP NIHaWJE4OiCq NGi3VlBl\WO{ZXHz[ZMhfGinIH3SUmEh\XiycnXzd4lwdiCxZjDQVmwuOyC|aXfubYZq[2GwdHz5 MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR5NUezN{c,OjV2N{W3N|M9N2F-
MKN28 NW\HPJBvTnWwY4Tpc44hSXO|YYm= M3zNZ|XDqM7:TR?= M{fyZVczKGh? M3S4eIRm[3KnYYPld{B1cGVibWLORUBmgHC{ZYPzbY9vKG:oIGDSUE0{KHOrZ37p[olk[W62bIm= NI\Iboo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS3OVc{Oyd-MkW0O|U4OzN:L3G+
SGC-7901 MVTGeY5kfGmxbjDBd5NigQ>? NVvod4xnPcLizszN NWXD[oc6PzJiaB?= NE\EblNl\WO{ZXHz[ZMhfGinIH3SUmEh\XiycnXzd4lwdiCxZjDQVmwuOyC|aXfubYZq[2GwdHz5 MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR5NUezN{c,OjV2N{W3N|M9N2F-
MKN45 MkDVSpVv[3Srb36gRZN{[Xl? MorNOeKh|ryP MYW3NkBp Mon0[IVkemWjc3XzJJRp\SCvUl7BJIV5eHKnc4Ppc44hd2ZiUGLMMVMhe2mpbnnmbYNidnSueR?= M4XucFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NEe1O|M{Lz5{NUS3OVc{OzxxYU6=
HREC Ml3TSpVv[3Srb36gRZN{[Xl? MWC1M|ExyqEQvF2= Mn3POFghcA>? MonUbY5lfWOnczDQSWRHKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTN3Mke0O{c,OjV|NUK3OFc9N2F-
HRPE NXPFOXhzTnWwY4Tpc44hSXO|YYm= MVm1M|ExyqEQvF2= NH;TTHQ1QCCq MomybY5lfWOnczDQSWRHKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz M3m4UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{WyO|Q4Lz5{NUO1Nlc1PzxxYU6=
HREC NWjpboEyTnWwY4Tpc44hSXO|YYm= NEDPcmM2NzFywrFOwG0> NYHjV5ZrPDhiaB?= MVnkc5dvNXKnZ4XsZZRmeyCxZjDWSWdHNCCLQ1HNMVEhMG6xdDDwdo91\WmwIHzleoVtKGmwIFjSVGUh[2WubIOpMEBKVC1zzsKg[I9{\S2mZYDlcoRmdnSueR?= M4f5bVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{WyO|Q4Lz5{NUO1Nlc1PzxxYU6=
HRPE M1S3e2Z2dmO2aX;uJGF{e2G7 NGrqdII2NzFywrFOwG0> NYnZN2JSPDhiaB?= NVLJ[4dz\G:5bj3y[Yd2dGG2ZYOgc4YhXkWJRjygTWwuOc7{LDDhcoQhVU2SMjDkc5NmNWSncHXu[IVvfGy7 NX\id2VKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOVI4PDdpPkK1N|UzPzR5PD;hQi=>
MSCs MljqSpVv[3Srb36gRZN{[Xl? M2nHWlExKM7:TR?= NV\OPVR6OjRiaB?= MonZdJJwdW:2ZYOgeIhmKGOxbX3peI1mdnRib3[gUXNEeyC2bzDtfY9k[XKmaXHsJIRq\m[ncnXueIlifGmxbh?= MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTN3MUO5OUc,OjV|NUGzPVU9N2F-
HL-60 M2qxWGZ2dmO2aX;uJGF{e2G7 NH;SfnA2KM7:TR?= NVXDOI5bPzJiaB?= M2rWXGROW09? NG\ISpJ{cWewaX\pZ4FvfGy7IIXwdoVofWyjdHXzJHpPTjN6MjDlfJBz\XO|aX;u MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTNzOUC0PUc,OjV|MUmwOFk9N2F-
MV4-11 MknLSpVv[3Srb36gRZN{[Xl? MnTNOUDPxE1? M{TzTVczKGh? NVmzZo5FTE2VTx?= NH7aT|N{cWewaX\pZ4FvfGy7IIXwdoVofWyjdHXzJHpPTjN6MjDlfJBz\XO|aX;u MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTNzOUC0PUc,OjV|MUmwOFk9N2F-
A2780 NYrldlRITnWwY4Tpc44hSXO|YYm= MUm1JOK2VcLi NFTqTmU4KGR? MoPKbY5kemWjc3XzJGRPSSCvZYTofYxifGmxbjDs[ZZmdA>? Mli2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{OUm2PVQoRjJ3Mkm5Olk1RC:jPh?=
CP70 NGjsPGdHfW6ldHnvckBCe3OjeR?= NWDuSlhTPSEEtV5CpC=> NXjJUpFnPyCm NU[zPJNncW6lcnXhd4V{KESQQTDt[ZRpgWyjdHnvckBt\X[nbB?= MnW3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{OUm2PVQoRjJ3Mkm5Olk1RC:jPh?=
A2780 M2HMXGZ2dmO2aX;uJGF{e2G7 NFz0S3A2KML3TdMg MVK3JIQ> NHzkXWt4\WGtZX7zJJRp\SCuZY\lcEBw\iCvZYTofYxifGmxbh?= NGPRfWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUK5PVY6PCd-MkWyPVk3QTR:L3G+
CP70 MoDjSpVv[3Srb36gRZN{[Xl? M{H5VVUhyrWPwrC= MVO3JIQ> MlTHe4Vic2WwczD0bIUhdGW4ZXygc4YhdWW2aInsZZRqd25? Mm\TQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{OUm2PVQoRjJ3Mkm5Olk1RC:jPh?=
OCM3 NHjtfmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXrvN5R[OC53L{GvNkDPxE1? M4\HS|ch\A>? MUPEUXNQ MmSwbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmKGSncHXu[IVvfCCvYX7u[ZI> NYXwZ49nRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
92.1 NUjZcGU1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVfWNmJDOC53L{GvNkDPxE1? MVm3JIQ> M1S0OGROW09? MXfpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uh\GWyZX7k[Y51KG2jbn7ldi=> M2e5fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
OCM1 M2r1Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXxNE42NzFxMjFOwG0> M{Pqclch\A>? NEjVe4FFVVOR Mon3bY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmKGSncHXu[IVvfCCvYX7u[ZI> NUD4co1ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
OMM1 NYnVZYlzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfCTYQxNjVxMT:yJO69VQ>? MoPwO{Bl M2nmSmROW09? NEXTPZpqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2ViZHXw[Y5l\W62IH3hco5meg>? NGf2VWM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
Mel 285 NIrzS3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVuwMlUwOS9{IN88US=> NGjKU4E4KGR? MkTXSG1UVw>? NYTOVZd2cW6qaXLpeJMh[2WubDDndo94fGhiaX6gZUBld3OnIHTldIVv\GWwdDDtZY5v\XJ? M3T6VVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
Mel 290 M{\GZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF7Dd24xNjVxMT:yJO69VQ>? NX3oNmZFPyCm M4HPNmROW09? MYfpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uh\GWyZX7k[Y51KG2jbn7ldi=> NVvoeJk{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
OCM3 MoDGSpVv[3Srb36gRZN{[Xl? MUCwMlUwOSEQvF2= M2SwWVQ5KGh? MoXkSG1UVw>? NWi0NXd1\GWlcnXhd4V{KGOub37v[4VvcWOrdImg[I9{\S2mZYDlcoRmdnSueR?= NVjGfoVtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
92.1 M3faN2Z2dmO2aX;uJGF{e2G7 NIqwXoExNjVxMTFOwG0> MUi0PEBp MoLsSG1UVw>? MmfH[IVkemWjc3XzJINtd26xZ3XubYNqfHliZH;z[U1l\XCnbnTlcpRtgQ>? M4[4flxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
OCM1 MWfGeY5kfGmxbjDBd5NigQ>? M133NlAvPS9zIN88US=> NXTEWYxjPDhiaB?= M2TRbWROW09? NGrsc5dl\WO{ZXHz[ZMh[2yxbn;n[Y5q[2m2eTDkc5NmNWSncHXu[IVvfGy7 M4G0[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
OMM1 NVvFb4p7TnWwY4Tpc44hSXO|YYm= NXvIT4pQOC53L{Gg{txO M3P1bVQ5KGh? MVnEUXNQ MUPk[YNz\WG|ZYOgZ4xwdm:pZX7pZ4l1gSCmb4PlMYRmeGWwZHXueIx6 NV;QNXlJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
Mel 285 NVrMT5RlTnWwY4Tpc44hSXO|YYm= MX[wMlUwOSEQvF2= NFWxcnY1QCCq NUfjWpdsTE2VTx?= M3fOToRm[3KnYYPld{BkdG:wb3flcolkcXS7IHTvd4Uu\GWyZX7k[Y51dHl? NF\t[ZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
Mel 290 NELhTG1HfW6ldHnvckBCe3OjeR?= M{m4U|AvPS9zIN88US=> M1q0NlQ5KGh? MXfEUXNQ NUn2bGdM\GWlcnXhd4V{KGOub37v[4VvcWOrdImg[I9{\S2mZYDlcoRmdnSueR?= MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
OCM3 NGG3WFNHfW6ldHnvckBCe3OjeR?= NF7hT|cxNjVxMTFOwG0> M3XxOVQ5KGh? NIfWZVRFVVOR NHPWb3Zl\WO{ZXHz[ZMhcW64YYPpc44h\G:|ZTDk[ZBmdmSnboTsfeKh MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
Mel 290 MV;GeY5kfGmxbjDBd5NigQ>? NGW3OoMxNjVxMTFOwG0> NWC5W5NWPDhiaB?= NX\pcZFXTE2VTx?= MlHV[IVkemWjc3XzJIlvfmG|aX;uJIRwe2ViZHXw[Y5l\W62bIpCpC=> MnvuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OMM1 NEHnU5pHfW6ldHnvckBCe3OjeR?= NI\hN|YxNjVxMTFOwG0> NGjsN5U1QCCq NXvI[2ppTE2VTx?= NV[3VoxU\GWlcnXhd4V{KGmwdnHzbY9vKGSxc3Wg[IVx\W6mZX70cJnDqA>? NV7VRYxNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
OCM1 Mk\sR4VtdCCYaXHibYxqfHliQYPzZZk> M3zOXFAvPS9zIN88US=> MmDsOUBl M4\MbWROW09? NV\JSGdx\GWlcnXhd4V{KHKjZHnheIlwdi2rbnT1Z4VlKGOnbHygeoli[mmuaYT5JIlvcGmkaYTpc44> NHjC[pM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
92.1 Ml7jR4VtdCCYaXHibYxqfHliQYPzZZk> MlThNE42NzFizszN NIjFfFE2KGR? MULEUXNQ MYXk[YNz\WG|ZYOgdoFlcWG2aX;uMYlv\HWlZXSgZ4VtdCC4aXHibYxqfHliaX7obYJqfGmxbh?= MkLNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OCM1 NHfoWo5HfW6ldHnvckBCe3OjeR?= NVy0UVlNOC53L{Gg{txO NFvjNJM1QCCq M3rIfGROW09? NVXpXnRK[2G3c3XzJIdtd2KjbDDEUmEhcHmyb33leIh6dGG2aX;uJIF1KExvMTDy[ZBm[XRibH;jbS=> MlnXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OCM3 M2jafGZ2dmO2aX;uJGF{e2G7 NYnBflBYOC53L{Gg{txO Mnq5OFghcA>? MX;EUXNQ MoHrZ4F2e2W|IHfsc4JidCCGTlGgbJlxd22ndHj5cIF1cW:wIHH0JGwuOSC{ZYDlZZQhdG:laR?= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
92.1 NXr6d4pkTnWwY4Tpc44hSXO|YYm= Mn\CNE42NzFizszN MnzpOFghcA>? NV\JbXNsTE2VTx?= MULjZZV{\XNiZ3zvZoFtKESQQTDofZBwdWW2aInsZZRqd25iYYSgUE0yKHKncHXheEBtd2Or M4rj[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
IMR32 NWrM[3FiTnWwY4Tpc44hSXO|YYm= Mk\oN{DPxE1? MlzyO|IhcA>? MmLjSG1UVw>? M1vzSIlv\HWlZYRCpJAyQS2LTlu0[OKh\XiycnXzd4lwdsLic3nncolncWOjboTsfS=> MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTFyNEi1NEc,OjVzMES4OVA9N2F-
IMR5-75 NEjmeodHfW6ldHnvckBCe3OjeR?= NUfBc3RKOyEQvF2= NFrGSXg4OiCq MVLEUXNQ NV3JNGRHcW6mdXPld:KheDF7LVnOT|RlyqCneIDy[ZN{cW:wwrDzbYdvcW[rY3HueIx6 NUPrc3JkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxNFQ5PTBpPkK1NVA1QDVyPD;hQi=>
Be(2)-C MlLxSpVv[3Srb36gRZN{[Xl? NEXWe5Q{KM7:TR?= MWe3NkBp NUPZeGZ1TE2VTx?= M33lR4lv\HWlZYRCpJAyQS2LTlu0[OKh\XiycnXzd4lwdsLic3nncolncWOjboTsfS=> M3;ZWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUC0PFUxLz5{NUGwOFg2ODxxYU6=
Bxpc-3 NFrLUW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHmZlhTPS9zMDFOwG0> M4\KfFI1NzR6L{eyJIg> MmDDbY5pcWKrdIOgeIhmKHC{b3zp[oVz[XSrb36gc4YhSniyYz2zJINmdGy|IHnuJJRqdWVvIHHu[EBkd26lZX70doF1cW:wLXTldIVv\GWwdDDtZY5v\XK| MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTB4MUezNUc,OjVyNkG3N|E9N2F-
Bxpc-3 M1HG[WFxd3C2b4Ppd{BCe3OjeR?= NFmycY42NzFyIN88US=> MUmyOE81QC95MjDo MVjpcoR2[2W|IHHwc5B1d3OrczDpckB1cW2nLTDhcoQh[2:wY3XycpRz[XSrb36gcYFvdmW{cx?= NYDyTJBbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwOlE4OzFpPkK1NFYyPzNzPD;hQi=>
Bxpc-3 MWTGeY5kfGmxbjDBd5NigQ>? M2PQ[VUwOTBizszN M13n[FI1NzR6L{eyJIg> NEH3W5Vl\WO{ZXHz[ZMh|rJvY3H0[Y5qdiCneIDy[ZN{cW:wIHHmeIVzKDJ2IHi= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTB4MUezNUc,OjVyNkG3N|E9N2F-
Bxpc-3 NETKe3VHfW6ldHnvckBCe3OjeR?= NHv2S402NzFyIN88US=> M3G1cVI1NzR6L{eyJIg> NG\KNJVl\WO{ZXHz[ZMh[3mlbHnuSFEh\XiycnXzd4lwdiCjdDD0bIUh[2:wY3XycpRz[XSrb36gc4YhOTBizszN NYfKNGMxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwOlE4OzFpPkK1NFYyPzNzPD;hQi=>
Bxpc-3 M37DbmZ2dmO2aX;uJGF{e2G7 NWj6eld5PS9zMDFOwG0> MonxNlQwPDhxN{KgbC=> MnvD[I94di2{ZXf1cIF1\VNiYz3tfYMhdVKQQTDlfJBz\XO|aX;uJIlvKHSrbXWtJIFv\CClb37j[Y51emG2aX;uMYRmeGWwZHXueEBu[W6wZYLz M16yZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3ME[xO|MyLz5{NUC2NVc{OTxxYU6=
HL-60 NXT0UHJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGDwTGsyNjBizszN MnTmOFghcA>? NH76dmR{cWewaX\pZ4FvfGy7IHnubIljcXS|IFjMMVYxKGOnbHyg[5Jwf3SqwrC= NFfSVno9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUC1NVEyQSd-MkWwOVEyOTl:L3G+
HL-60 Ml3LSpVv[3Srb36gRZN{[Xl? M1\FZ|EvOCEQvF2= NEDQSGI1QCCq M1vCcIlv[3KnYYPld{BxOjGZQV[xM2NKWDIEoHHu[EBk[XOyYYPlMVMh\XiycnXzd4lwdsLi NX7lTnptRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwOVEyOTlpPkK1NFUyOTF7PD;hQi=>
HL-60 M3TybWZ2dmO2aX;uJGF{e2G7 NUPySWk1OS5yIN88US=> NXfEd2RSPDhiaB?= NXm1NYdk\GWlcnXhd4V{KEKlbD34UEBmgHC{ZYPzbY9vyqC|aXfubYZq[2GwdHz5 M4HXN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MEWxNVE6Lz5{NUC1NVEyQTxxYU6=
HuTu-80  M2DXeWZ2dmO2aX;uJGF{e2G7 NFnJS5kyNzVxMUCg{txO MmHrOFgwPzJiaB?= NH;Qd3VqdmO{ZXHz[ZMhfGinIHX4dJJme3Orb36gc4YhcHWvYX6gUnBEOUxzIH3SUmEhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> M1fVWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUC0NFYzLz5{NEmwOFA3OjxxYU6=
Caco2  NEDMd|lHfW6ldHnvckBCe3OjeR?= MYCxNEDPxE1? NHLsUXk1QCCq MVjpcoNz\WG|ZYOgUnBEOUxzIHX4dJJme3Orb36= M1;KPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUC0NFYzLz5{NEmwOFA3OjxxYU6=
HepG2  M4D4c2Z2dmO2aX;uJGF{e2G7 NFLVdpkxNTJ3IN88US=> NGWyeZEzPCCq MlXu[IVkemWjc3XzJJN2[nSrbHnzbY4wc2W6aX6geJlx\SB7IDjQR3NMQSlicILveIVqdiCuZY\lcJMh\G:|ZTDk[ZBmdmSnboTsfS=> NYnQe|Z1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HepG2  MUTGeY5kfGmxbjDBd5NigQ>? MlzQNE0zPSEQvF2= NV\FUZdKOjRiaB?= MnO4bY5kemWjc3XzJIxwfyCmZX7zbZR6KGyrcH;wdo91\WmwIILlZ4VxfG:{IDjMSGxTMSCpZX7lJIV5eHKnc4Ppc47DqA>? NVnEU5RKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HepG2  MkHYSpVv[3Srb36gRZN{[Xl? M2LuUFExKM7:bdMg NWW5eZJTOC1{NDDo NVz2RlVU\GWlcnXhd4V{yqCSQ2PLPeKh[W6mwrDIUWdEWsLiZYjwdoV{e2mxbjDhcoQhcW6lcnXhd4V{KEyGTGKg[ZhxemW|c3nvckBi\nSncjC2JIg> NV\RR3VsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HepG2  NVLofXlzTnWwY4Tpc44hSXO|YYm= Ml\ENVAh|ryv MYiyOEBp MVHwdo9ud3SnczDjfZRwe2:uaXOgcoV2fHKjbDDsbZBq\CCjY3P1cZVt[XSrb36gbY5l\XCnbnTlcpRtgSCxZjDlfI9o\W6xdYOgcIlxd3C{b4TlbY5{ M{jG[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEW1OlQ3Lz5{NEi1OVY1PjxxYU6=
HepG2  NVjiR5lNTnWwY4Tpc44hSXO|YYm= MXGxNEDPxG1? MoHoNlQhcA>? MkDkdJJmfmWwdIOgV3JGSlBicILvZ4V{e2mwZx?= NXn5c2JQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HC45  MVjGeY5kfGmxbjDBd5NigQ>? NFuzRXM2yrWPwrC= NYHScHo2PCCm MmXpdoVlfWOnczD0bIUhdWW2aInsZZRqd25ibHX2[Yx{KG:oIGfJSlEtKFBzNjygR3hEVDF2LDDOT3gz6oDVMzygR2RJOSxiTFHNRVEtKGGwZDDDWG5PSjF? NUTtPG1SRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OlI5ODlpPkK0O|YzQDB7PD;hQi=>
CNDT2  NWm1TZdnTnWwY4Tpc44hSXO|YYm= NET5dXU2yrWPwrC= NVTuNpRyPCCm MVPy[YR2[2W|IITo[UBu\XSqeXzheIlwdiCuZY\lcJMhd2ZiV1nGNUwhWDF4LDDDXGNNOTRuIF7LXFLjiJN|LDDDSGgyNCCOQV3BNUwh[W6mIFPUUm5DOQ>? MkToQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NkK4NFkoRjJ2N{[yPFA6RC:jPh?=
CNDT2  M2fq[mZ2dmO2aX;uJGF{e2G7 NWWwN|I4PcL3TdMg NHXwd|I1KGR? MXvpcoNz\WG|ZYOg[4Vv\SCneIDy[ZN{cW:wIH;mxsBYUUZzLDDQNVYtKEOGSEGsxsBNSU2DMT|CpIFv\MLiQ2TOUmIy MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd4MkiwPUc,OjR5NkK4NFk9N2F-
T-cells NVL2OGNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoqyOU8zOCEQvF2= NG\ZbocxNTR6IHi= NHzCN5FqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2ViZHXw[Y5l\W62IH3hco5meg>? NGPmc249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe1O|I5Oyd-MkS3OVczQDN:L3G+
CD3+ T-cells NFzHToJHfW6ldHnvckBCe3OjeR?= M1jmV|UwOjBizszN MUC0PEBp M2PnUpVxemWpdXzheIV{KHBzNTDlfJBz\XO|aX;u MkSzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells M{m1ZmZ2dmO2aX;uJGF{e2G7 MljpOU8zOCEQvF2= MVy0PEBp Mn\oeZBz\We3bHH0[ZMheDF3IHX4dJJme3Orb36= M1y3[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD8+ T-cells Mo\nSpVv[3Srb36gRZN{[Xl? NXi0OXdiPS9{MDFOwG0> NHTnOWE1QCCq Mni4eZBz\We3bHH0[ZMheDF3IHX4dJJme3Orb36= MlW0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD3+ T-cells MUnGeY5kfGmxbjDBd5NigQ>? NXm3[mI4PS9{MDFOwG0> MXm0PEBp M1LCV5VxemWpdXzheIV{KHSqZTDlfJBz\XO|aX;uJI9nKE[RWGCz MofPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells MVvGeY5kfGmxbjDBd5NigQ>? MWK1M|IxKM7:TR?= MVm0PEBp NYLLVIZpfXC{ZXf1cIF1\XNidHjlJIV5eHKnc4Ppc44hd2ZiRl;YVFM> NFLCPXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe1O|I5Oyd-MkS3OVczQDN:L3G+
CD4+ T-cells NWjX[297TnWwY4Tpc44hSXO|YYm= M1L3O|UwOjBizszN NEW4Nmk1QCCq NIfEVpRz\WS3Y3XzJHRDTVRzwrDtVm5CKGW6cILld5Nqd25? MnS3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells MV\GeY5kfGmxbjDBd5NigQ>? NFqzeoQ2NzJyIN88US=> NVv5N5dXPDhiaB?= M3PkUJVxemWpdXzheIV{KHSqZTDlfJBz\XO|aX;uJI9nyqCUT2NOt5TDqA>? M{\s[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD4+ T-cells MoK2SpVv[3Srb36gRZN{[Xl? MnvPOU8zOCEQvF2= MYC0PEBp M4m3XYlvcGmkaYTzJI1mdW:{eTDUMYNmdGy| NImwdXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe1O|I5Oyd-MkS3OVczQDN:L3G+
CD8+ T-cells NV;vTG5FTnWwY4Tpc44hSXO|YYm= MmDDOU8zOCEQvF2= NGHPR|g1QCCq M1;NNYlvcGmkaYTzJI1mdW:{eTDUMYNmdGy| M2PMRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD3+ T-cells MXfGeY5kfGmxbjDBd5NigQ>? NYTpcm15PSEQvF2= MYq0PEBp NXvxN|lnemWmdXPld{Btd26pLYTldo0hdWWvb4L5JINmdGxicHjlco91gXCn NWDPbmdSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OVczQDNpPkK0O|U4Ojh|PD;hQi=>
U937 NVX3NINDSXCxcITvd4l{KEG|c3H5 M3nNblExKM7:TR?= MYC3NkBp MWfpcoR2[2W|IHHwc5B1d3OrczDzbYdvcW[rY3HueIx6 Mmm0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4OEC4OlUoRjJ2NkiwPFY2RC:jPh?=
HL-60 MYfBdI9xfG:|aYOgRZN{[Xl? NH7TSWgyOCEQvF2= NUnhbnhpPzJiaB?= NUPmOFlPcW6mdXPld{BieG:ydH;zbZMhe2mpbnnmbYNidnSueR?= NVjjSnliRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFA5PjVpPkK0OlgxQDZ3PD;hQi=>
MCF7 MoHtSpVv[3Srb36gRZN{[Xl? MVq1JO69VQ>? MmqzOFghcMLi NEPNPY1lcXOybHH5d{B{\WynY4TpeoUhfG:6aXPpeJkhfG:5YYLkJJN2e3CnbnTl[EBOS0ZvNzDj[Yxtew>? MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ|M{O1NEc,OjR4M{OzOVA9N2F-
MCF7 NF7meI5HfW6ldHnvckBCe3OjeR?= Mo\BNVAh|ryP M{\5S|I1KGkEoB?= MnTNbY5lfWOnczD0bIUh[2ynYY\h[4Uhd2ZiY3HzdIF{\SB5IHHu[EBRSVKSwrC= NHTJe3g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zN|M2OCd-MkS2N|M{PTB:L3G+
MCF7 MWrGeY5kfGmxbjDBd5NigQ>? NFjBR5Qx6oDVMD61JO69VcLi Mn\LO{Bl NGLqXG5qdmirYnn0d{B1cGViZ4Lve5RpKE2FRj23JJR2dW:{c4Do[ZJmeyCrbjDzeZNx\W6|aX;uJIN2dHS3cnXzxsA> M3TNT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkOzN|UxLz5{NE[zN|M2ODxxYU6=
MCF7 MXrGeY5kfGmxbjDBd5NigQ>? NIO3e4UxNjVizszNxsA> MV2xOEBl MoPRdoVlfWOnczD0bIUhe2m8ZTDv[kBOS0ZvNzDjc4xwdmmnczDlcYJm\GSnZDDpckB{d2[2IHHnZZI> Mn;SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
MCF7 NGXUXYZHfW6ldHnvckBCe3OjeR?= MUewMlA26oDVMkCg{txO M33FbFEh\A>? MWry[YR2[2W|IITo[UBkdG:wYXygd5Vzfmm4YXygc4YhVUOILUegZ4VtdHNiaX6gcY9vd2yjeXXyJIN2dHS3cnXz NFrITIc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zN|M2OCd-MkS2N|M{PTB:L3G+
T47D  MnvKSpVv[3Srb36gRZN{[Xl? M37ocFAvPSEQvF2= MmDEOEBl M3TXdYlvcGmkaYTzJJR2dW:{c4Do[ZJmKG[xcn3heIlwdg>? M1W1PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkOzN|UxLz5{NE[zN|M2ODxxYU6=
MCF7 MnTaSpVv[3Srb36gRZN{[Xl? NXmzW2RSOC534pETNVAh|ryP MkLGOFghcMLi MUnpcohq[mm2czD0bIUh\2GyIHPsc5N2emViaX6geIhmKHexdX7kJIhm[WyrbnegZZN{[Xl? NGfTfGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zN|M2OCd-MkS2N|M{PTB:L3G+
MCF7 NWO2XmdbTnWwY4Tpc44hSXO|YYm= NHK1cm4xNzFyIN88US=> NWXtZZkyOjRiaB?= M1e4OolvcGmkaYTzJJRp\SCjY4Tpeol1gSCxZjDNUXA6 MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ|M{O1NEc,OjR4M{OzOVA9N2F-
MDA-MB-231  MWTGeY5kfGmxbjDBd5NigQ>? NGW1dmgxNjYkgKOxNEDPxE1? MWezOkBp MXTpcohq[mm2czD0bIUhdWmpcnH0bY9v MmjTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
SKM1-S NXT0b5VuSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NIPtPGw1QCCqcoO= NV;ab4cySW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT20yNVNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JHhVXCCjc4PhfUwhUUN3MDC9JFAvPSEQvF2u NIjoN2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEC5OFk{QCd-MkiwPVQ6Ozh:L3G+
SKM1-S NXXxUYllSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= Mn;MOFghcHK| MVPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONTUGtV{Bk\WyuczDh[pRmeiB2ODDodpMh[nliRFHQTU1{fGGrbnnu[{1j[XOnZDDmcI94KGO7dH;t[ZRzcWNibXX0bI9lNCCHQ{WwJF0hOC53MTFOwG0v MkXIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjhyOUS5N|goRjJ6MEm0PVM5RC:jPh?=
A427 M1fOVmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M3jOPVk3KGi{cx?= MYfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF2MkegZ4VtdHNiYX\0[ZIhQTZiaILzJIJ6KGO{eYP0ZYwhfmmxbHX0JIF{e2G7LDDJR|UxKD1iMD62N{DPxE1w NEX3OHc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOESzOFE3Oyd-MUi0N|QyPjN:L3G+
KYSE70 NYSx[oRuSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1TjbVk3KGi{cx?= NGfDN3hCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFvZV2U4OCClZXzsd{Bi\nSncjC5OkBpenNiYomgZ5J6e3SjbDD2bY9t\XRiYYPzZZktKEmFNUCgQUAyNjV7IN88UU4> M1;PelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEO0NVY{Lz5zOESzOFE3OzxxYU6=
5637 M1q2RmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NULHe|RPQTZiaILz M13lWmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iNU[zO{Bk\WyuczDh[pRmeiB7NjDodpMh[nliY4L5d5RidCC4aX;s[ZQh[XO|YYmsJGlEPTBiPTCxMlc{KM7:TT6= M4XtNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEO0NVY{Lz5zOESzOFE3OzxxYU6=
HT-29 MVXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NGLZS|g6PiCqcoO= NH\VNGtCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUMVI6KGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCzMlgh|ryPLh?= MlzFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd5OES0PUc,Ojd5OES0PVww[T5?
P388 NFvOO4lCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NXG4R3VpPDhiaILz M3LQSGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViUEO4PEBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iNTFOwG0v NWewWZZqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3PFQ1QSd-Mke3PFQ1QTxxYU6=
MCF7 MUXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NFTjSIc6PiCqcoO= M3rzcWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB7NjDodpMh[nliY4L5d5RidCC4aX;s[ZQh[XO|YYmsJGlEPTBiPTC2Mlc5KM7:TT6= MoK0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh2M{SxOlMoRjF6NEO0NVY{RC:jPh?=
U373-MAGI M1K0b2FvfGm4aYLhcEBie3OjeR?= M{f1b|I2KHSxIESwNEB2VQ>? NHy2NnQzKHSxIEeyJIhzew>? NUDrPFlESW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhXlOYLVegdJNmfWSxdInw[YQhUEmYLUGgUmw1NTNiaX7m[YN1\WRiaX6gbJVu[W5iVUO3N{1OSUeLIHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBo[WdibHX2[Ywh[XRiMkWgeI8hPDByIIXNJIFnfGW{IEKgeI8hPzJiaILzJIJ6KHGSQ2KgcYV1cG:m NIfVV2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{GxO|I3OCd-MkexNVczPjB:L3G+
U373-MAGI M{\oPWFvfGm4aYLhcEBie3OjeR?= Ml;uNlUhfG9iNECwJJVO NFH4SoQzKHSxIEeyJIhzew>? MVzBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDWV3YuTyCyc3X1[I91gXCnZDDITXYuOSCQTEStN{Bqdm[nY4Tl[EBqdiCqdX3hckBWOzd|LV3BS2kh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIGW1MYdi\yCuZY\lcEBifCB{NTD0c{A1ODBidV2gZYZ1\XJiMjD0c{A4OiCqcoOgZpkheVCFUjDt[ZRpd2R? M3zxfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MUG3NlYxLz5{N{GxO|I3ODxxYU6=
L1210 MlvhR5l1d3SxeHnjbZR6KGG|c3H5 M1rVV2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJGwyOjFyIHPlcIx{KGG|c3Xzd4VlKGG|IHPld5NifGmxbjDv[kBoem:5dHi= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek83QTB{Nje+OlkxOjZ:L3G+
TC32 M{m3b5FJXFNiYYPzZZk> MnHYdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFSFM{KgZ4VtdHN? NV:zcHJFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
A673 Mn61dWhVWyCjc4PhfS=> MUfxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 MVPxTHRUKGG|c3H5 NULZeJY2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFLUMVM4KGOnbHzz Mn;pQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
RD NVLhT4NDeUiWUzDhd5NigQ>? MmTqdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{ M4CwPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-12 Mkj6dWhVWyCjc4PhfS=> NHL4UJNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= NIL5bI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB1643 MlvJdWhVWyCjc4PhfS=> NUi4XphVeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CNVY1OyClZXzsdy=> MmHsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
OHS-50 MX;xTHRUKGG|c3H5 M2PYNpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCRSGOtOVAh[2WubIO= MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC NW\meZlWeUiWUzDhd5NigQ>? M3X4cZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz M3zqXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SKM1-S M{i1cGFxd3C2b4Ppd{Bie3OjeR?= M3P1[|EhfU1? MoXGTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCVS12xMXMh[2WubIOgZZN{\XO|ZXSgZZMh[2G|cHHz[UA{KGOuZXH2ZYdmKGG2IEGgeW0h[nliV3XzeIVzdiCkbH;0JI1mfGixZB?= NXz0dYJXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiwPVQ6OzhpPkK4NFk1QTN6PD;hQi=>
MCF7 MUjGeY5kfGmxbjDhd5NigQ>? MoOzNVUhfU1? M4jEc|czKGi{cx?= MlfuTY5pcWKrdHnvckBw\iCXSGLGNUBqdiCqdX3hckBOS0Z5IHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJI1mfGi7bHH0bY9vKGG2IGLBVkBj\XSjIHX4c44h[XRiMUWgeW0h[W[2ZYKgO|IhcHK|IHL5JI1mfGi7bHH0bY9vKHOyZXPp[olkNVCFUjDt[ZRpd2R? MknsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyNEm1O|coRjJ5MES5OVc4RC:jPh?=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
DNMT1 ; 

PubMed: 28210112     


AZA and DAC cause DNMT1 depletion in NSCLC cell lines. A549 and H1299 cells were treated with AZA or DAC (0–5 µM) for 20 hours and DNMT1 protein was detected by Western blotting of cell extracts. Alpha-tubulin was used as a loading control.

c-PARP / p-H2AX / H2AX; 

PubMed: 28210112     


AZA, but not DAC, induces markers of DNA damage and apoptosis in NSCLC cell lines. A549 and H1299 cells were treated with AZA or DAC (0–10 µM) for 48 hours and Western blotting of cell extracts was used to detect DNMT1, cleaved-PARP, phospho-histone-H2AX(䲧疝Ỵ疞㧀疜膉痘 瘿뙠ෆᾰƌෆĀ 㺣痖帉痖Ѐ瑖堘

28210112
Immunofluorescence
HMGB1 ; 

PubMed: 29097772     


U2OS cells stably expressing a GFP-HMGB1 fusion were maintained in control conditions (Ctrl), suberoylanilide hydroxamic acid (SAHA), azacitidine (AZA) for 24 h or 48 h, followed by assessment of cytoplasmic GFP-HMGB1 fluorescence intensity (A,B) or endog䲧疝Ỵ疞㧀疜膉痘 瘿뙠ෆᾰƌෆĀ 㺣痖帉痖Ѐ瑖堘𢡄빢᎒ෆĀ鑸᎒彿堙奋堙巫堙᎒ﻺ᎒彿堙ﻮ᎒塚堙ﻺ᎒ꍈ堞빢᎒學堙漸堞圔堙빢᎒圞堙圭堙𢡄玚Wᾰƌ ᾰƌ戤瘯Ɖ⟸෕䐺痖暼瘿⟸෕ᾰƌ ⟸෕Ð㺣痖⟸෕€𢡄⟼෕€䀷痗⟼෕౴⟼෕㵶痗⟼෕뺖᎒泌Itemセ᎒

29097772
Growth inhibition assay
Cell viability ; 

PubMed: 28210112     


AZA and DAC differentially affect cell viability in a panel of NSCLC cell lines. Viability of A549, H460, and H1299 cells was assessed after 72 hours of treatment with AZA or DAC (0–25 µM). Error bars represent the standard error of mean of 3 independent 䲧疝Ỵ疞㧀疜膉痘 瘿뙠ෆᾰƌෆĀ 㺣痖

28210112
In vivo Azacitidine inhibits polynucleotide synthesis in leukemic BDF1 mice. [3] Azacitidine (3 mg/kg, i.p.) increases the mean survival time in leukemic BDF1 mice inoculated with Ll210 ascites tumor cells. Azacitidine markedly suppresses all enzymes activity in the polyamine-biosynthetic pathway, including ornithine decarboxylase activity. putrescine-dependent S-adenosyl-L-methionine decarboxylase activity, and spermidine-dependent S-adenosyl-L-methionine decarboxylase activity. Azacitidine also inhibits the accumulations of polyamines in leukemic mice. [4]

Protocol

Cell Research:[3]
- Collapse
  • Cell lines: Leukemia L1210 cell
  • Concentrations: 0.15 μg/mL
  • Incubation Time: 3 days
  • Method: 5 mL of L1210 cells (5 × 103 cells/mL) are incubated with Azacitidine at 37 ℃ for 3 days. Cell number is determined twice a day for 3 days by means of a Model A Coulter counter.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: BDF1 mice bearing lymphoid leukemia L1210
  • Dosages: 3 mg/kg
  • Administration: Daily i.p. injection
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 48 mg/mL warmed (196.56 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+ddH2O
For best results, use promptly after mixing.
10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 244.2
Formula

C8H12N4O5

CAS No. 320-67-2
Storage powder
in solvent
Synonyms 5-AzaC,Ladakamycin, AZA,5-Aza, CC-486
Smiles C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04638309 Recruiting Drug: APR-548 + Azacitidine MDS|Myelodysplastic Syndromes Aprea Therapeutics April 2021 Phase 1
NCT04806906 Recruiting Drug: CC-486 MDS|CMML University of Florence March 2021 Phase 2
NCT04742101 Recruiting Drug: S65487 and azacitidine Acute Myeloid Leukemia Institut de Recherches Internationales Servier|ADIR a Servier Group company|Servier March 10 2021 Phase 1|Phase 2
NCT04629443 Not yet recruiting Drug: S 64315 (also referred as MIK665) and azacitidine Acute Myeloid Leukaemia Institut de Recherches Internationales Servier|ADIR a Servier Group company|Servier November 16 2020 Phase 1|Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    Is the vehicle (30% Propylene glycol, 5% Tween 80, 65% D5W) for Azacitidine (Catalog No.S1782) safe for subcutaneous dosing?

  • Answer:

    S1782 in 30% Propylene glycol+5% Tween 80+65% D5W at 30mg/ml is a suspension. If you are going to administrate this compound for oral gavage, it is fine. But if you administrate the drug via injection, you need a clear solution and S1782 can be dissolved in 5% DMSO+30% PEG 300+ddH2O at 10mg/ml clearly.

DNA Methyltransferase Signaling Pathway Map

Tags: buy Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) supplier | purchase Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) cost | Azacitidine (5-Azacytidine) manufacturer | order Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID